Nuclear medicine: policy context for differences between Europe and the United States
The World Health Organization published in 2004 a bulletin addressing the gap between research, technology, and its implementation in the health systems of different countries (Haines, Kuruvilla, & Borchert, 2004). Among the barriers described for the implementation of new knowledge in the medi...
Main Author: | Roldan Rueda, Diana Marcela |
---|---|
Other Authors: | Cozzens, Susan |
Format: | Others |
Language: | en_US |
Published: |
Georgia Institute of Technology
2015
|
Subjects: | |
Online Access: | http://hdl.handle.net/1853/53389 |
Similar Items
-
Nuclear medicine and molecular imaging in clinical practice: yesterday, today and tomorrow
by: Vladimir B. Sergienko, et al.
Published: (2021-04-01) -
Nuclear Weapons in Europe: around the Status Quo
by: A. V. Zagorski
Published: (2018-12-01) -
Radiolabeled Dendrimers for Nuclear Medicine Applications
by: Lingzhou Zhao, et al.
Published: (2017-08-01) -
Nuclear Medicine in the Context of Personalized Medicine
Published: (2020) -
Generic Medicine Pricing Policies in Europe: Current Status and Impact
by: Pieter Dylst, et al.
Published: (2010-03-01)